Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Controlled Trial ◽

Inhibitor Therapy ◽

Randomized Controlled ◽

Prevention Of Osteoporosis

Protocol for Exercise Program in Cancer and Cognition (EPICC): A randomized controlled trial of the effects of aerobic exercise on cognitive function in postmenopausal women with breast cancer receiving aromatase inhibitor therapy

Contemporary Clinical Trials ◽

10.1016/j.cct.2018.02.012 ◽

2018 ◽

Vol 67 ◽

pp. 109-115 ◽

Cited By ~ 6

Author(s):

Amanda L. Gentry ◽

Kirk I. Erickson ◽

Susan M. Sereika ◽

Frances E. Casillo ◽

Mary E. Crisafio ◽

...

Keyword(s):

Breast Cancer ◽

Cognitive Function ◽

Aerobic Exercise ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Controlled Trial ◽

Exercise Program ◽

Randomized Controlled

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1351-3 ◽

2011 ◽

Vol 126 (2) ◽

pp. 295-310 ◽

Cited By ~ 60

Author(s):

Susan F. Dent ◽

Rania Gaspo ◽

Michelle Kissner ◽

Kathleen I. Pritchard

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Management Strategies ◽

Inhibitor Therapy ◽

Hormone Sensitive

Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT

Breast Diseases A Year Book Quarterly ◽

10.1016/s1043-321x(09)79195-7 ◽

2009 ◽

Vol 20 (1) ◽

pp. 94-95

Author(s):

Y.H. Chia ◽

C.X. Ma

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Controlled Trial ◽

Inhibitor Therapy ◽

Double Blind ◽

Hormone Receptor Positive

Bisphosphonates May Protect against Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Aromatase Inhibitor Therapy: Results from a Meta-analysis

Archives of Medical Research ◽

10.1016/j.arcmed.2014.10.007 ◽

2014 ◽

Vol 45 (7) ◽

pp. 570-579 ◽

Cited By ~ 3

Author(s):

Guoqiang Su ◽

Yi Xiang ◽

Guodong He ◽

Chenchun Jiang ◽

Chuang Li ◽

...

Keyword(s):

Breast Cancer ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Meta Analysis ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer

BMC Cancer ◽

10.1186/1471-2407-13-239 ◽

2013 ◽

Vol 13 (1) ◽

Cited By ~ 10

Author(s):

Yutaka Yamamoto ◽

Takashi Ishikawa ◽

Yasuo Hozumi ◽

Masahiko Ikeda ◽

Hiroji Iwata ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Hormone Receptor ◽

Controlled Trial ◽

Metastatic Breast ◽

Randomized Controlled ◽

Hormone Receptor Positive

Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

JAMA Network Open ◽

10.1001/jamanetworkopen.2019.11080 ◽

2019 ◽

Vol 2 (9) ◽

pp. e1911080 ◽

Cited By ~ 3

Author(s):

Rebecca Pedersini ◽

Vito Amoroso ◽

Filippo Maffezzoni ◽

Fabio Gallo ◽

Antonella Turla ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Body Mass ◽

Early Breast Cancer ◽

Vertebral Fractures ◽

Fat Body ◽

Inhibitor Therapy ◽

Fat Body Mass

A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer

Cancer Prevention Research ◽

10.1158/1940-6207.capr-17-0187 ◽

2017 ◽

Vol 10 (12) ◽

pp. 710-718 ◽

Cited By ~ 29

Author(s):

Hamed Samavat ◽

Giske Ursin ◽

Tim H. Emory ◽

Eunjung Lee ◽

Renwei Wang ◽

...

Keyword(s):

Breast Cancer ◽

Postmenopausal Women ◽

Green Tea ◽

Mammographic Density ◽

Controlled Trial ◽

Green Tea Extract ◽

Randomized Controlled ◽

Increased Risk ◽

Tea Extract

Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-017-2140-z ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 6

Author(s):

Wei Hao ◽

Sheng Liu ◽

Yuenong Qin ◽

Chenping Sun ◽

Liying Chen ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Study Protocol ◽

Controlled Trial ◽

Cardioprotective Effect ◽

Platycodon Grandiflorum ◽

Randomized Controlled ◽

Chemotherapy Study

Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer

Breast Care ◽

10.1159/000350777 ◽

2013 ◽

Vol 8 (2) ◽

pp. 110-120 ◽

Cited By ~ 3

Author(s):

Nadia Harbeck ◽

Maria Blettner ◽

Peyman Hadji ◽

Christian Jackisch ◽

Hans-Joachim Lück ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Randomized Study ◽

Patient Characteristics ◽

Population Based ◽

Baseline Data ◽

Hormone Sensitive

A Patient- and Assessor-Blinded Randomized Controlled Trial of Axillary Reverse Mapping (ARM) in Patients with Early Breast Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3337898 ◽

2019 ◽

Author(s):

Martinus A. Beek ◽

Paul D Gobardhan ◽

Elisabeth G Klompenhouwer ◽

Marian B Menke-Pluijmers ◽

Pascal Steenvoorde ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Controlled Trial ◽

Axillary Reverse Mapping ◽

Randomized Controlled ◽

Reverse Mapping